GLYMAB THERAPEUTICS LIMITED
GLYMAB THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 16538942, incorporated on 24 June 2025. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). Registered office address: OX4 4GD Oxford, the United Kingdom. Directors include ALEXANDER HAYWARD, PROFESSOR LINDA GILLIAN DURRANT, and DR PHILLIP JOHN L'HUILLIER. Sole shareholder is SCANCELL HOLDINGS PLC. Associated with 4 related entities, including SCANCELL HOLDINGS PLC, 13408042, and 06029507. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
THE BELLHOUSE BUILDING SANDERS ROAD
OXFORD SCIENCE PARK
OX4 4GD OXFORD
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (1)
| Date | Change | Details |
|---|---|---|
| 2026-04-26 | SECRETARY ADDED | Alexander Hayward (secretary) |
Source Records (1)
| companieshouse | 16538942 | 2026-06-01 | open_in_new |